| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.8M | +50.2% | +210.3% |
| SG&A Expense | $3.1M | +33.6% | +154.6% |
| Operating Income | -$6.9M | -42.2% | -182.3% |
| Net Income | -$6.9M | -51.6% | -139.3% |
| EPS (Basic) | -$0.21 | -10.5% | -16.7% |
| EPS (Diluted) | -$0.21 | -10.5% | -16.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.3M | -34.7% | +17.8% |
| Total Assets | $9.0M | -13.2% | +352.8% |
| Current Liabilities | $4.1M | +19.9% | +60.4% |
| Total Liabilities | $4.2M | +19.3% | +58.1% |
| Stockholders' Equity | $3.6M | -26.4% | +614.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.5M | — | — |
| Investing Cash Flow | -$466K | — | — |
| Financing Cash Flow | $7.3M | — | — |